Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Abgrall

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy eraS Abgrall, C Rabaud, D Costagliola, et al.
Pathologie-Biologie|February 16, 2000
[Recent data from the literature on the biological and pathologic effects of electromagnetic radiation, radio waves and stray currents]S Orbach-Arbouys, S Abgrall, A Bravo-Cuellar
La Revue De Medecine Interne|January 1, 1997
[Leaving the table on the knees!]S Abgrall, A M Piette, P Graveleau, et al.
Revue Neurologique|April 1, 1995
[Cerebral infarction disclosing neurocysticercosis]S Sangla, T De Broucker, S Abgrall, et al.
Anticancer Research|January 30, 2003
Tumors in organ transplant recipients may give clues to their control by immunityS Abgrall, D Orbach, L Bonhomme-Faivre, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2001
Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analoguesS Abgrall, I Charreau, V Joly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxisS Abgrall, S Matheron, V Le Moing, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Lactobacillus casei infection in an AIDS patientS Abgrall, V Joly, P Derkinderen, et al.
The Journal of Antimicrobial Chemotherapy|November 12, 2009
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?I Kousignian, O Launay, C Mayaud, et al.
Medecine Et Maladies Infectieuses|August 31, 2010
[Multidrug-resistant tuberculosis management in three French hospitals]S Greffe, I Gros, P Cruaud, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2001
Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy eraS Abgrall, C Rabaud, D Costagliola, et al.
Pathologie-Biologie|February 16, 2000
[Recent data from the literature on the biological and pathologic effects of electromagnetic radiation, radio waves and stray currents]S Orbach-Arbouys, S Abgrall, A Bravo-Cuellar
La Revue De Medecine Interne|January 1, 1997
[Leaving the table on the knees!]S Abgrall, A M Piette, P Graveleau, et al.
Revue Neurologique|April 1, 1995
[Cerebral infarction disclosing neurocysticercosis]S Sangla, T De Broucker, S Abgrall, et al.
Anticancer Research|January 30, 2003
Tumors in organ transplant recipients may give clues to their control by immunityS Abgrall, D Orbach, L Bonhomme-Faivre, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2001
Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analoguesS Abgrall, I Charreau, V Joly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxisS Abgrall, S Matheron, V Le Moing, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
Lactobacillus casei infection in an AIDS patientS Abgrall, V Joly, P Derkinderen, et al.
The Journal of Antimicrobial Chemotherapy|November 12, 2009
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?I Kousignian, O Launay, C Mayaud, et al.
Medecine Et Maladies Infectieuses|August 31, 2010
[Multidrug-resistant tuberculosis management in three French hospitals]S Greffe, I Gros, P Cruaud, et al.
Pageof 3